Biogen and Neomorph have entered a research partnership aimed at discovering and developing molecular glue degraders for the ...

That differentiates them from some other protein degrader technologies that still need a binding site ... San Diego, California-based Neomorph was set up in 2020 by investment group Deerfield ...

Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platform Neomorph to receive an upfront payment and is ...